1. Home
  2. AVLN vs HLIT Comparison

AVLN vs HLIT Comparison

Compare AVLN & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$33.84

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$12.02

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVLN
HLIT
Founded
N/A
1988
Country
United States
United States
Employees
N/A
559
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
AVLN
HLIT
Price
$33.84
$12.02
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$14.67
AVG Volume (30 Days)
175.5K
1.5M
Earning Date
N/A
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
N/A
Revenue This Year
N/A
$42.73
Revenue Next Year
N/A
$18.36
P/E Ratio
N/A
$236.00
Revenue Growth
N/A
N/A
52 Week Low
$24.90
$8.47
52 Week High
$40.17
$17.68

Technical Indicators

Market Signals
Indicator
AVLN
HLIT
Relative Strength Index (RSI) 47.59 43.96
Support Level $34.22 $11.45
Resistance Level $40.08 $12.48
Average True Range (ATR) 1.96 0.37
MACD -0.39 -0.03
Stochastic Oscillator 9.89 17.57

Price Performance

Historical Comparison
AVLN
HLIT

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: